Publications by authors named "Shenggen Wang"
Article Synopsis
- - Colon cancer is a prevalent type of malignant tumor in the digestive system, and while oxaliplatin is used for treatment, it often yields poor results.
- - Researchers tested an IDO inhibitor called D-MT in combination with oxaliplatin on mice with colon cancer, examining aspects like immune cell activity and tumor growth.
- - The results indicated that this combination therapy not only reduced tumor growth and boosted survival rates in mice but also increased the presence of vital immune cells, suggesting a promising new approach for treating colon cancer, particularly in patients who may not respond well to oxaliplatin alone.
Background: Bile acid diarrhoea or BAD is a common but little recognised cause of chronic diarrhoea. Few of these patients in China have been diagnosed due to a lack of diagnostic options.
Aims: To clarify the diagnostic value of serum fibroblast growth factor19 (FGF19) in BAD patients.